Search Results 2151-2160 of 27596 for virus

  1. Lifileucel (intravenous route) - Side effects & uses - Mayo Clinic

    Drug Interactions · Adenovirus Vaccine Type 4, Live · Adenovirus Vaccine Type 7, Live · Cholera Vaccine · Ebola Zaire Vaccine, Live · Influenza Virus Vaccine, Live ...

  2. Cefpodoxime (oral route) - Side effects & dosage - Mayo Clinic

    However, this medicine will not work for colds, flu, or other virus infections. This medicine is available only with your doctor's prescription. This ...

  3. FrαDcs Or Placebo For Patients With Advanced Stage Ovarian Cancer - Mayo Clinic

    ... viral load within 6 months are eligible for this trial. For patients with evidence of hepatitis B virus (HBV) infection, the HBV viral load must be ...

  4. Mayo Clinic Q&A - Dr. Gregory Poland - CAPTIONS - 4 27 22

    The virus could care less that we're fatigued of these precautions. It will exploit and take advantage of that. Narrator 00:16. So, we're talking masking ...

  5. Pemetrexed (intravenous route) - Side effects & uses - Mayo Clinic

    Measles Virus Vaccine, Live; Mumps Virus Vaccine, Live; Rubella Virus Vaccine, Live; Smallpox Monkeypox Vaccine; Typhoid Vaccine; Varicella Virus Vaccine ...

  6. Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma - Mayo Clinic

    viral load - ELIGIBILITY CRITERIA (STEP 1): Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable ...

  7. Phantosmia: What causes olfactory hallucinations? - Mayo Clinic

    An olfactory hallucination, known as phantosmia, makes you detect smells that aren't in your environment. The odors you notice in phantosmia are different ...

  8. Safety Study of SEA-CD40 in Cancer Patients - Mayo Clinic

    Participation eligibility · Any active Grade 3 or higher (per the NCI CTCAE, version 4.03) viral, bacterial, or fungal infection requiring systemic therapy ...

  9. A Study To Evaluate The Effectiveness, Safety, And Tolerability Of BOS-589 In The Treatment Of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

    ... viral load at least 6 months after completion of treatment can be demonstrated. Human immunodeficiency virus (HIV)-1 or HIV-2 antibody positive. Prior ...

  10. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    Subjects with primary cutaneous large B-cell lymphoma, EBV (Epstein-Barr virus) positive DLBCL, Burkitt lymphoma or transformation from chronic lymphocytic ...